Risk of Autistic Disorder in Affected Offspring of Mothers With a Glutathione S-Transferase P1 Haplotype | Autism Spectrum Disorders | JAMA Pediatrics | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
April 2007

Risk of Autistic Disorder in Affected Offspring of Mothers With a Glutathione S-Transferase P1 Haplotype

Author Affiliations

Author Affiliations: Departments of Neurology (Drs Williams and Johnson, Mr Stenroos, and Ms Wang) and Pediatrics (Drs Mars, Factura-Santiago, and Lambert) and Center for Childhood Neurotoxicology and Exposure Assessment (Drs Mars, Lambert, and Johnson), University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, Piscataway, and Departments of Statistics and Genetics, Rutgers University, New Brunswick, NJ (Dr Buyske).

Arch Pediatr Adolesc Med. 2007;161(4):356-361. doi:10.1001/archpedi.161.4.356

Objective  To test whether polymorphisms of the glutathione S-transferase P1 gene (GSTP1) act in the mother during pregnancy to contribute to the phenotype of autistic disorder (AD) in her fetus.

Design  Transmission disequilibrium testing (TDT) in case mothers and maternal grandparents.

Setting  Autistic disorder may result from multiple genes and environmental factors acting during pregnancy and afterward. Teratogenic alleles act in mothers during pregnancy to contribute to neurodevelopmental disorders in their offspring; however, only a handful have been identified. GSTP1 is a candidate susceptibility gene for AD because of its tissue distribution and its role in oxidative stress, xenobiotic metabolism, and JNK regulation.

Participants  We genotyped GSTP1*G313A and GSTP1*C341T polymorphisms in 137 members of 49 families with AD. All probands received a clinical diagnosis of AD by Autism Diagnostic Interview–Revised and Autism Diagnostic Observation Schedule–Generic testing.

Main Outcome Measures  Association of haplotypes with AD was tested by the TDT-Phase program, using the expectation-maximization (EM) algorithm for uncertain haplotypes and for incomplete parental genotypes, with standard measures of statistical significance.

Results  The GSTP1*A haplotype was overtransmitted to case mothers (P = .01 [P = .03 using permutation testing]; odds ratio, 2.67 [95% confidence interval, 1.39-5.13]). Results of the combined haplotype and genotype analyses suggest that the GSTP1-313 genotype alone determined the observed haplotype effect.

Conclusions  Overtransmission of the GSTP1*A haplotype to case mothers suggests that action in the mother during pregnancy likely increases the likelihood of AD in her fetus. If this is confirmed and is a result of a gene-environment interaction occurring during pregnancy, these findings could lead to the design of strategies for prevention or treatment.